Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 24

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Impact of Alcohol and Coffee Intake on the Risk of Advanced Liver Fibrosis: A Longitudinal Analysis in HIV-HCV Coinfected Patients (ANRS CO-13 HEPAVIH Cohort)

Yaya, Issifou, Marcellin, Fabienne, Costa, Marie, Morlat, Philippe, Protopopescu, Camelia, Pialoux, Gilles, Santos, Melina Erica, Wittkop, Linda, Esterle, Laure, Gervais, Anne, Sogni, Philippe, Salmon-Ceron, Dominique, Carrieri, Maria Patrizia, The ANRS CO13-HEPAVIH Cohort Study Group·2018·Nutrients
DOI 10.3390/nu10060705
Open this paper in CoChat — free account

Abstract

Background: Coffee intake has been shown to modulate both the effect of ethanol on serum GGT activities in some alcohol consumers and the risk of alcoholic cirrhosis in some patients with chronic diseases. This study aimed to analyze the impact of coffee intake and alcohol consumption on advanced liver fibrosis (ALF) in HIV-HCV co-infected patients. Methods: ANRS CO13-HEPAVIH is a French, nationwide, multicenter cohort of HIV-HCV-co-infected patients. Sociodemographic, behavioral, and clinical data including alcohol and coffee consumption were prospectively collected using annual self-administered questionnaires during five years of follow-up. Mixed logistic regression models were performed, relating coffee intake and alcohol consumption to ALF. Results: 1019 patients were included. At the last available visit, 5.8% reported high-risk alcohol consumption, 27.4% reported high coffee intake and 14.5% had ALF. Compared with patients with low coffee intake and high-risk alcohol consumption, patients with low coffee intake and low-risk alcohol consumption had a lower risk of ALF (aOR (95% CI) 0.24 (0.12–0.50)). In addition, patients with high coffee intake had a lower risk of ALF than the reference group (0.14 (0.03–0.64) in high-risk alcohol drinkers and 0.11 (0.05–0.25) in low-risk alcohol drinkers). Conclusions: High coffee intake was associated with a low risk of liver fibrosis even in HIV-HCV co-infected patients with high-risk alcohol consumption.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/nu10060705

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 55

  1. Pawlotsky, 2004, Pathophysiology of hepatitis C virus infection and related liver disease, Trends Microbiol., 12, 96, 10.1016/j.tim.2003.12.005 · DOI
  2. Castello, 2010, HCV-related hepatocellular carcinoma: From chronic inflammation to cancer, Clin. Immunol., 134, 237, 10.1016/j.clim.2009.10.007 · DOI
  3. Moqueet, N., Kanagaratham, C., Gill, M.J., Hull, M., Walmsley, S., Radzioch, D., Saeed, S., Platt, R.W., Klein, M.B., and Canadian Co-infection Cohort Study (CTN 222) (2017). A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection. PLoS ONE, 12. · DOI
  4. Marcellin, 2002, Fibrosis and disease progression in hepatitis C, Hepatology, 36, s47, 10.1002/hep.1840360707 · DOI · Paper page
  5. Joshi, 2016, Alcoholic Liver Disease: High Risk or Low Risk for Developing Hepatocellular Carcinoma?, Clin. Liver Dis., 20, 563, 10.1016/j.cld.2016.02.012 · DOI · Paper page
  6. Liu, F., Wang, X., Wu, G., Chen, L., Hu, P., Ren, H., and Hu, H. (2015). Coffee Consumption Decreases Risks for Hepatic Fibrosis and Cirrhosis: A Meta-Analysis. PLoS ONE, 10. · DOI
  7. Alferink, 2017, Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study, J. Hepatol., 67, 339, 10.1016/j.jhep.2017.03.013 · DOI
  8. Heckman, 2010, Caffeine (1, 3, 7-trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters, J. Food Sci., 75, R77, 10.1111/j.1750-3841.2010.01561.x · DOI · Paper page
  9. Grosso, 2017, Coffee, Caffeine, and Health Outcomes: An Umbrella Review, Annu. Rev. Nutr., 37, 131, 10.1146/annurev-nutr-071816-064941 · DOI · Paper page
  10. Grosso, 2016, Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: A dose-response meta-analysis, Eur. J. Epidemiol., 31, 1191, 10.1007/s10654-016-0202-2 · DOI
  11. Alicandro, 2017, Coffee and cancer risk: A summary overview, Eur. J. Cancer Prev., 26, 424, 10.1097/CEJ.0000000000000341 · DOI
  12. Carrieri, 2014, Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: Results from the ANRS CO13 HEPAVIH cohort study, J. Hepatol., 60, 46, 10.1016/j.jhep.2013.08.014 · DOI
  13. Oh, 2016, Coffee consumption is associated with lower serum aminotransferases in the general Korean population and in those at high risk for hepatic disease, Asia Pac. J. Clin. Nutr., 25, 767
  14. Morisco, 2014, Coffee and liver health, J. Clin. Gastroenterol., 48, S87, 10.1097/MCG.0000000000000240 · DOI
  15. Stroffolini, 2010, Interaction of alcohol intake and cofactors on the risk of cirrhosis, Liver Int., 30, 867, 10.1111/j.1478-3231.2010.02261.x · DOI
  16. Freedman, 2009, Coffee Intake Is Associated with Lower Rates of Liver Disease Progression in Chronic Hepatitis C, Hepatology, 50, 1360, 10.1002/hep.23162 · DOI · Paper page
  17. Carrieri, 2012, Coffee consumption and reduced self-reported side effects in HIV-HCV co-infected patients during PEG-IFN and ribavirin treatment: Results from ANRS CO13 HEPAVIH, J. Hepatol., 56, 745, 10.1016/j.jhep.2011.08.005 · DOI
  18. Shim, 2013, Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model, J. Gastroenterol. Hepatol., 28, 1877, 10.1111/jgh.12317 · DOI
  19. Bai, 2016, Coffee consumption and risk of hepatocellular carcinoma: A meta-analysis of eleven epidemiological studies, OncoTargets Ther., 9, 4369, 10.2147/OTT.S109656 · DOI
  20. Loko, M.-A., Salmon, D., Carrieri, P., Winnock, M., Mora, M., Merchadou, L., Gillet, S., Pambrun, E., Delaune, J., and Valantin, M.A. (2010). The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006–2010. BMC Infect. Dis., 10. · DOI
  21. Sterling, 2006, Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection, Hepatology, 43, 1317, 10.1002/hep.21178 · DOI · Paper page
  22. Carrieri, M.P., Protopopescu, C., Marcellin, F., Rosellini, S., Wittkop, L., Esterle, L., Zucman, D., Raffi, F., Rosenthal, E., and Poizot-Martin, I. (2017). Protective effect of coffee consumption on all-cause mortality of French HIV-HCV co-infected patients. J. Hepatol. · DOI
  23. Labarga, 2015, Liver fibrosis progression despite HCV cure with antiviral therapy in HIV-HCV-coinfected patients, Antivir. Ther., 20, 329, 10.3851/IMP2909 · DOI
  24. Oze, 2014, Coffee and green tea consumption is associated with upper aerodigestive tract cancer in Japan, Int. J. Cancer, 135, 391, 10.1002/ijc.28653 · DOI
  25. Grosso, 2017, Coffee consumption and mortality in three Eastern European countries: Results from the HAPIEE (Health, Alcohol and Psychosocial factors in Eastern Europe) study, Public Health Nutr., 20, 82, 10.1017/S1368980016001749 · DOI
  26. Kennedy, 2016, Systematic review with meta-analysis: Coffee consumption and the risk of cirrhosis, Aliment. Pharmacol. Ther., 43, 562, 10.1111/apt.13523 · DOI
  27. Setiawan, 2017, Coffee Drinking and Alcoholic and Nonalcoholic Fatty Liver Diseases and Viral Hepatitis in the Multiethnic Cohort, Clin. Gastroenterol. Hepatol., 15, 1305, 10.1016/j.cgh.2017.02.038 · DOI
  28. Jaruvongvanich, 2017, Effects of caffeine consumption in patients with chronic hepatitis C: A systematic review and meta-analysis, Clin. Res. Hepatol. Gastroenterol., 41, 46, 10.1016/j.clinre.2016.05.012 · DOI
  29. Larsson, 2007, Coffee Consumption and Risk of Liver Cancer: A Meta-Analysis, Gastroenterology, 132, 1740, 10.1053/j.gastro.2007.03.044 · DOI · Paper page
  30. Nieber, 2017, The Impact of Coffee on Health, Planta Med., 83, 1256, 10.1055/s-0043-115007 · DOI
  31. Shi, 2013, Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway, Toxicology, 303, 107, 10.1016/j.tox.2012.10.025 · DOI
  32. Lim, 2014, Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients, Clin. Infect. Dis., 58, 1449, 10.1093/cid/ciu097 · DOI
  33. Marcellin, 2014, High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: A sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort, Clin. Infect. Dis., 59, 1190, 10.1093/cid/ciu525 · DOI
  34. Balasubramanian, 2005, Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV, Clin. Infect. Dis., 41, S32, 10.1086/429493 · DOI
  35. Mascia, 2017, Active HCV infection is associated with increased circulating levels of interferon-gamma (IFN-γ)-inducible protein-10 (IP-10), soluble CD163 and inflammatory monocytes regardless of liver fibrosis and HIV coinfection, Clin. Res. Hepatol. Gastroenterol., 41, 644, 10.1016/j.clinre.2017.04.007 · DOI
  36. Negash, A.A., Ramos, H.J., Crochet, N., Lau, D.T., Doehle, B., Papic, N., Delker, D.A., Jo, J., Bertoletti, A., and Hagedorn, C.H. (2013). IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease. PLoS Pathog., 9. · DOI · Paper page
  37. Czaja, 2014, Hepatic inflammation and progressive liver fibrosis in chronic liver disease, World J. Gastroenterol., 20, 2515, 10.3748/wjg.v20.i10.2515 · DOI · Paper page
  38. Morales, 2005, Assessing the antioxidant activity of melanoidins from coffee brews by different antioxidant methods, J. Agric. Food Chem., 53, 7832, 10.1021/jf0512353 · DOI · Paper page
  39. Uribe, 2012, High coffee intake is associated with lower grade nonalcoholic fatty liver disease: The role of peripheral antioxidant activity, Ann. Hepatol., 11, 350, 10.1016/S1665-2681(19)30931-7 · DOI
  40. Labarga, 2014, Changes in liver fibrosis in HIV/HCV-coinfected patients following different outcomes with peginterferon plus ribavirin therapy, J. Viral Hepat., 21, 475, 10.1111/jvh.12180 · DOI
  41. Barreiro, 2014, Liver fibrosis progression in HIV-HCV-coinfected patients treated with distinct antiretroviral drugs and impact of pegylated interferon/ribavirin therapy, Antiviral Ther., 19, 287, 10.3851/IMP2703 · DOI
  42. ANRS CO13 HEPAVIH Cohort (2015). Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients. AIDS, 29, 1821–1830. · DOI
  43. Fontana, 2009, Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis, Clin. Gastroenterol. Hepatol., 7, 219, 10.1016/j.cgh.2008.10.034 · DOI
  44. Berenguer, 2009, Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus, Hepatology, 50, 407, 10.1002/hep.23020 · DOI · Paper page
  45. Benhamou, 1999, Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group, Hepatology, 30, 1054, 10.1002/hep.510300409 · DOI
  46. Graham, 2001, Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis, Clin. Infect. Dis., 33, 562, 10.1086/321909 · DOI
  47. Salvatore, 2006, Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy, J. Hepatol., 44, 47, 10.1016/j.jhep.2005.07.006 · DOI
  48. Lapidus, 2008, Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: Analysis of risk factors, Clin. Infect. Dis., 46, 768, 10.1086/527565 · DOI
  49. Collazos, 2012, Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients, J. Viral Hepat., 19, 685, 10.1111/j.1365-2893.2012.01596.x · DOI
  50. Dyal, 2015, Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis among HCV Patients: A Systematic Review, Dig. Dis. Sci., 60, 2813, 10.1007/s10620-015-3760-3 · DOI
  51. Asselah, 2013, Insulin resistance: A major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C, Eur. J. Gastroenterol. Hepatol., 25, 421, 10.1097/MEG.0b013e32835c9f69 · DOI
  52. Hu, 2009, Factors Associated with Hepatic Fibrosis in Patients with Chronic Hepatitis C: A Retrospective Study of a Large Cohort of U.S. Patients, J. Clin. Gastroenterol., 43, 758, 10.1097/MCG.0b013e31818be17c · DOI
  53. Younossi, 2004, Obesity and non-alcoholic fatty liver disease in chronic hepatitis C, J. Clin. Gastroenterol., 38, 705, 10.1097/01.mcg.0000135372.10846.2a · DOI
  54. Kennedy, 2017, Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: A systematic review and dose-response meta-analysis, BMJ Open, 7, e013739, 10.1136/bmjopen-2016-013739 · DOI · Paper page
  55. Godos, J., Micek, A., Marranzano, M., Salomone, F., Rio, D.D., and Ray, S. (2017). Coffee Consumption and Risk of Biliary Tract Cancers and Liver Cancer: A Dose-Response Meta-Analysis of Prospective Cohort Studies. Nutrients, 9. · DOI

Cited by

Metadata

Authors
Yaya, I., Marcellin, F., Costa, M., Morlat, P., Protopopescu, C., Pialoux, G., Santos, M. E., Wittkop, L., Esterle, L., Gervais, A., Sogni, P., Salmon-Ceron, D., Carrieri, M. P., & The ANRS CO13-HEPAVIH Cohort Study Group
Venue
Nutrients
Publisher
MDPI AG
Published
2018-05-31
Volume
10
Issue
6
Pages
705
ISSN
2072-6643
DOI
10.3390/nu10060705
Cited by
24
References
3
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
  • Agence Nationale de Recherches sur le Sida et les Hépatites Virales (-)
  • Abbott France (-)
  • GlaxoSmithKline (-)
  • Roche (-)
  • Schering-Plough (-)
  • Institut National de la Santé et de la Recherche Médicale (-)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.